United States · FDA National Drug Code directory
Valsartan and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82868-054_5502ebf5-b02f-5b67-e063-6294a90a2aeb
- Product NDC
- 82868-054
- Form
- TABLET
- Composition / generic term
- Valsartan and Hydrochlorothiazide
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240521
- Source listing expiry
- 20271231
Source-listed ingredients
- VALSARTAN — 160 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (82868-054-30) · 82868-054-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →